These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27099322)

  • 1. FDA requires boxed warning for all immediate-release opioid products.
    Thompson CA
    Am J Health Syst Pharm; 2016 May; 73(9):e114-5. PubMed ID: 27099322
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA Boxed Warning for Immediate-Release Opioids.
    Food And Drug Administration Public Health Service U S Department Of Health And Human Services
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):141-5. PubMed ID: 27301692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning.
    Zhang VS; Olfson M; King M
    JAMA Psychiatry; 2019 Nov; 76(11):1208-1210. PubMed ID: 31532463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights and issues from FDA Advisory Committee meetings on abuse-deterrent opioids.
    Miller CJ; Dart RC; Katz NP; Webster LR
    J Opioid Manag; 2017; 13(6):379-389. PubMed ID: 29308585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efforts aim to curb opioid deaths, injuries.
    Kuehn BM
    JAMA; 2009 Mar; 301(12):1213-5. PubMed ID: 19318643
    [No Abstract]   [Full Text] [Related]  

  • 6. Spell out 'acetaminophen' for patients' sake, group says.
    Thompson CA
    Am J Health Syst Pharm; 2011 Oct; 68(19):1768. PubMed ID: 21930631
    [No Abstract]   [Full Text] [Related]  

  • 7. What drug labels don't tell you.
    Consum Rep; 2011 Aug; 76(8):10. PubMed ID: 21770080
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights October-December 2015.
    Office of Health & Constituent Affairs U.S. Food and Drug Administration
    Am J Health Syst Pharm; 2016 Mar; 73(5):267. PubMed ID: 26896495
    [No Abstract]   [Full Text] [Related]  

  • 9. Requirements for FDA-approved patient information spelled out in final rule.
    Am J Health Syst Pharm; 1999 Jan; 56(2):107-8. PubMed ID: 10030523
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Clin Pharm; 1993 Jan; 12(1):6. PubMed ID: 8428434
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):739-40. PubMed ID: 27208054
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Am J Hosp Pharm; 1993 Jan; 50(1):13, 16. PubMed ID: 8427271
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries of safety labeling changes approved by FDA-boxed warnings highlights January-March 2016.
    Am J Health Syst Pharm; 2016 Jun; 73(11):e375-7. PubMed ID: 27208062
    [No Abstract]   [Full Text] [Related]  

  • 15. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summaries of safety labeling changes approved by FDA-Boxed Warnings Highlights October-December 2014.
    Rubio T
    Am J Health Syst Pharm; 2015 Mar; 72(5):343. PubMed ID: 25694404
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpreting labels of abuse-deterrent opioid analgesics.
    Webster LR
    J Opioid Manag; 2017; 13(6):415-423. PubMed ID: 29308588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing Antipsychotic Medications to Patients With Dementia: Boxed Warnings and Mitigation of Legal Liability.
    Rose RV; Kass JS
    Continuum (Minneap Minn); 2019 Feb; 25(1):254-259. PubMed ID: 30707196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Formulation Advances in Extended-Release Medications for Pain Control.
    Jones MR; Carney MJ; Kaye RJ; Prabhakar A; Kaye AD
    Curr Pain Headache Rep; 2016 Jun; 20(6):36. PubMed ID: 27084375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA to tighten labeling on long acting opioids.
    McCarthy M
    BMJ; 2013 Sep; 347():f5581. PubMed ID: 24030791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.